Question Everything. See who's reporting it.

Bombay High Court orders withdrawal of FDA's Cipla Pune license cancellation

Source: India Today

The story in brief

The Bombay High Court criticized the Maharashtra FDA for improperly canceling Cipla Pune's drug sale license, ordering the decision to be withdrawn. The FDA had canceled the license for irregularities in packaging, storage, and recall of Reactin Plus Tablets, but the court found the process violated natural justice. The regulator promised to issue a fresh show-cause notice and a reasoned decision after hearing Cipla's response.

2 outletsSee what the other 1 outlet said

NEWXFree on Android and iPhone. Open in NEWX